Scientists have achieved a “striking” reversal of Alzheimer’s disease in mice by restoring the normal function of the brain's vasculature—the network of blood vessels that supplies it with oxygen and nutrients

Patients with advanced triple-negative breast cancer who are ineligible for immune checkpoint inhibitors lived longer without disease progression when treated with the antibody–drug conjugate sacituzumab govitecan, with a median progression-free survival of 9.7 vs 6.9 months.

A new method can help scientists “see” the proteins that may trigger Parkinson’s disease (PD) in human brain tissue for the very first time.

A new simple blood test could provide faster and more accurate diagnosis of ALS by measuring cell-free DNA, and this test could eventually allow neurologists to rule out other neurological diseases and also detect ALS disease earlier to provide better treatment and improve life expectancy

A specific subset of children with autism may experience positive outcomes from taking memantine, a drug used to slow Alzheimer's disease, according to the results of a small clinical trial.

A high-fat, low-carb ketogenic diet may protect the brain from early Alzheimer’s disease changes in people genetically at risk, new research in mouse models of Alzheimer’s suggests, by rebalancing gut bacteria and restoring brain energy metabolism.

Older men are more likely to pass on disease-causing mutations to their children because of the faster growth of mutant cells in the testes with age

Huntington's disease treated for first time

Breakthrough Gene Therapy Slows Huntington's Disease by 75% : ScienceAlert

Women who miss first breast cancer screening at ‘40% higher risk’ of dying from the disease